IL94147A - Polyamines useful as antagonists of excitatory amino acid neurotransmitters and/or as blockers of calcium channels - Google Patents

Polyamines useful as antagonists of excitatory amino acid neurotransmitters and/or as blockers of calcium channels

Info

Publication number
IL94147A
IL94147A IL9414790A IL9414790A IL94147A IL 94147 A IL94147 A IL 94147A IL 9414790 A IL9414790 A IL 9414790A IL 9414790 A IL9414790 A IL 9414790A IL 94147 A IL94147 A IL 94147A
Authority
IL
Israel
Prior art keywords
compound
formula
cys
fraction
amino acid
Prior art date
Application number
IL9414790A
Other languages
English (en)
Other versions
IL94147A0 (en
Original Assignee
Pfizer
Natural Product Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer, Natural Product Sciences Inc filed Critical Pfizer
Priority to IL11252290A priority Critical patent/IL112522A/xx
Publication of IL94147A0 publication Critical patent/IL94147A0/xx
Publication of IL94147A publication Critical patent/IL94147A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C239/00—Compounds containing nitrogen-to-halogen bonds; Hydroxylamino compounds or ethers or esters thereof
    • C07C239/08—Hydroxylamino compounds or their ethers or esters
    • C07C239/16—Hydroxylamino compounds or their ethers or esters having nitrogen atoms of hydroxylamino groups further bound to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43518—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from spiders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Insects & Arthropods (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Neurosurgery (AREA)
  • Genetics & Genomics (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Reproductive Health (AREA)
  • Vascular Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
IL9414790A 1989-04-28 1990-04-20 Polyamines useful as antagonists of excitatory amino acid neurotransmitters and/or as blockers of calcium channels IL94147A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL11252290A IL112522A (en) 1989-04-28 1990-04-20 Polyamines useful as blockers of calcium channels and pharmaceutical compositions comprising same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US34618189A 1989-04-28 1989-04-28

Publications (2)

Publication Number Publication Date
IL94147A0 IL94147A0 (en) 1991-01-31
IL94147A true IL94147A (en) 1998-10-30

Family

ID=23358305

Family Applications (3)

Application Number Title Priority Date Filing Date
IL9414790A IL94147A (en) 1989-04-28 1990-04-20 Polyamines useful as antagonists of excitatory amino acid neurotransmitters and/or as blockers of calcium channels
IL11252290A IL112522A (en) 1989-04-28 1990-04-20 Polyamines useful as blockers of calcium channels and pharmaceutical compositions comprising same
IL11252295A IL112522A0 (en) 1989-04-28 1995-02-02 Polypeptides useful as blockers of calcium channels

Family Applications After (2)

Application Number Title Priority Date Filing Date
IL11252290A IL112522A (en) 1989-04-28 1990-04-20 Polyamines useful as blockers of calcium channels and pharmaceutical compositions comprising same
IL11252295A IL112522A0 (en) 1989-04-28 1995-02-02 Polypeptides useful as blockers of calcium channels

Country Status (25)

Country Link
EP (2) EP0395357B1 (fr)
JP (8) JPH0774187B2 (fr)
KR (2) KR920007554B1 (fr)
CN (2) CN1038931C (fr)
AT (1) ATE131813T1 (fr)
AU (1) AU615144B2 (fr)
CA (2) CA2015505C (fr)
CZ (1) CZ283830B6 (fr)
DD (2) DD298412A5 (fr)
DE (1) DE69024253T2 (fr)
DK (1) DK0395357T3 (fr)
EG (1) EG19311A (fr)
ES (1) ES2081929T3 (fr)
FI (1) FI902139A7 (fr)
GR (1) GR3018976T3 (fr)
HU (1) HU223593B1 (fr)
IE (2) IE69848B1 (fr)
IL (3) IL94147A (fr)
NO (1) NO300128B1 (fr)
NZ (2) NZ233469A (fr)
PL (1) PL165148B1 (fr)
PT (1) PT93876B (fr)
RU (1) RU2037498C1 (fr)
YU (1) YU84590A (fr)
ZA (1) ZA903229B (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5122596A (en) * 1989-09-29 1992-06-16 Pfizer Inc. Polypeptides useful as blockers of calcium channels
US5037846A (en) * 1990-01-02 1991-08-06 Pfizer Inc. Indolyl-3 polyamines and their use as antagonists of excitatory amino acid neurotransmitters
US5312928A (en) * 1991-02-11 1994-05-17 Cambridge Neuroscience Calcium channel antagonists and methodology for their identification
US5461032A (en) * 1991-03-01 1995-10-24 Fmc Corporation Insecticidally effective peptides
US6011068A (en) * 1991-08-23 2000-01-04 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
DE69233586T2 (de) * 1991-08-23 2006-09-28 NPS Pharmaceuticals, Inc., Salt Lake City Kalzium-Rezeptor aktive Verbindungen
US5858684A (en) * 1991-08-23 1999-01-12 The Brigham And Women's Hospital, Inc. Method of screening calcium receptor-active molecules
US5185369A (en) * 1991-08-23 1993-02-09 Pfizer Inc. Synthetic heteroaryl polyamines as excitatory amino acid neurotransmitter antagonists
US5763569A (en) * 1991-08-23 1998-06-09 The Brigham And Women's Hospital, Inc Calcium receptor-active molecules
US6313146B1 (en) 1991-08-23 2001-11-06 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US5688938A (en) * 1991-08-23 1997-11-18 The Brigham & Women's Hospital, Inc. Calcium receptor-active molecules
US6031003A (en) * 1991-08-23 2000-02-29 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US6001884A (en) * 1991-08-23 1999-12-14 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
IL104419A0 (en) * 1992-01-24 1993-05-13 Fmc Corp Insecticidally effective peptides
US5763568A (en) * 1992-01-31 1998-06-09 Zeneca Limited Insecticidal toxins derived from funnel web (atrax or hadronyche) spiders
US5962314A (en) * 1993-02-23 1999-10-05 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
AU3777093A (en) * 1993-02-23 1994-09-14 Brigham And Women's Hospital Calcium receptor-active molecules
US5457178A (en) * 1993-07-07 1995-10-10 Fmc Corporation Insecticidally effective spider toxin
JPH09505058A (ja) * 1993-11-15 1997-05-20 ベイカー・メディカル・リサーチ・インスティテュート 心機能不全の治療方法およびそのために有用な医薬組成物
EP1275635A1 (fr) 1994-10-21 2003-01-15 Nps Pharmaceuticals, Inc. Composés capables de moduler l'activité du récepteur de calcium
US5869602A (en) * 1995-03-17 1999-02-09 Novo Nordisk A/S Peptide derivatives
US5756459A (en) * 1995-06-07 1998-05-26 Fmc Corporation Insecticidally effective peptides isolatable from phidippus spider venom
US6271196B1 (en) * 1996-03-05 2001-08-07 Regents Of The University Of Ca Methods of alleviating neuropathic pain using prosaposin-derived peptides
JP4117506B2 (ja) * 1996-05-01 2008-07-16 エヌピーエス ファーマシューティカルズ インコーポレイテッド 無機イオン活性化合物
AUPO733397A0 (en) * 1997-06-13 1997-07-10 University Of Sydney, The Pesticidal compounds
CN1071115C (zh) * 1998-08-07 2001-09-19 彭小平 一种治疗胃肠炎及溃疡的复方药
FR2802817B1 (fr) * 1999-12-23 2002-10-11 Centre Nat Rech Scient Nouveaux inhibiteurs de glycosidases et leurs applications pharmacologiques, notamment pour traiter le diabete
WO2001070773A2 (fr) * 2000-03-22 2001-09-27 Basf Ag Peptides insecticides et procedes d"utilisation de ceux-ci
FR2820136A1 (fr) * 2001-01-26 2002-08-02 Aventis Pharma Sa Nouveaux derives de l'uree, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilisation
FR2885129B1 (fr) 2005-04-29 2007-06-15 Proskelia Sas Nouveaux derives de l'ureee substituee parun thiazole ou benzothiazole, leur procede de preparation, leur application a titre de medicaments, les compositions pharmaceutiques les renfermant et utilisation.
CN108949771B (zh) * 2018-08-02 2021-10-19 南京农业大学 拟环纹豹蛛c家族杀虫基因及其编码的成熟肽与应用
EP4390515A1 (fr) 2022-12-22 2024-06-26 Carl Zeiss Vision International GmbH Verre de lunettes et procédé de génération de données de conception pour un verre de lunettes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4950739A (en) * 1988-02-10 1990-08-21 New York University Membrane calcium channels and factors and methods for blocking, isolating and purifying calcium channels
GB8820442D0 (en) * 1988-08-30 1988-09-28 Usherwood P N R Therapeutic polyamine amides

Also Published As

Publication number Publication date
DD293959A5 (de) 1991-09-19
ATE131813T1 (de) 1996-01-15
CN1038931C (zh) 1998-07-01
NO901881D0 (no) 1990-04-27
YU84590A (sh) 1992-09-07
IL112522A (en) 2005-12-18
CS215790A3 (en) 1992-02-19
JP2747279B2 (ja) 1998-05-06
IE901496L (en) 1990-10-28
JPH09118693A (ja) 1997-05-06
KR920007554B1 (ko) 1992-09-07
ZA903229B (en) 1991-12-24
PT93876A (pt) 1990-11-20
CA2194103C (fr) 2000-01-04
JPH07165793A (ja) 1995-06-27
ES2081929T3 (es) 1996-03-16
AU5453590A (en) 1990-11-08
CZ283830B6 (cs) 1998-06-17
JPH09118692A (ja) 1997-05-06
CN1136960A (zh) 1996-12-04
JP2746361B2 (ja) 1998-05-06
DE69024253D1 (de) 1996-02-01
EP0395357A2 (fr) 1990-10-31
IL112522A0 (en) 1995-05-26
HU223593B1 (hu) 2004-09-28
AU615144B2 (en) 1991-09-19
GR3018976T3 (en) 1996-05-31
EP0696578A3 (fr) 1998-04-29
RU2037498C1 (ru) 1995-06-19
JP2744904B2 (ja) 1998-04-28
CA2015505A1 (fr) 1990-10-28
KR930000163B1 (ko) 1993-01-11
IL94147A0 (en) 1991-01-31
NZ244480A (fr) 1994-12-22
CN1047078A (zh) 1990-11-21
EG19311A (en) 1995-02-28
EP0395357A3 (fr) 1992-04-01
PL165148B1 (en) 1994-11-30
KR900015745A (ko) 1990-11-10
JP2691141B2 (ja) 1997-12-17
JP2746360B2 (ja) 1998-05-06
JPH09118694A (ja) 1997-05-06
PT93876B (pt) 1996-09-30
JPH0774187B2 (ja) 1995-08-09
CA2015505C (fr) 1997-03-11
JPH09118690A (ja) 1997-05-06
IE950345L (en) 1990-10-28
EP0395357B1 (fr) 1995-12-20
JP2746359B2 (ja) 1998-05-06
NZ233469A (fr) 1994-12-22
JPH09118691A (ja) 1997-05-06
FI902139A7 (fi) 1990-10-29
HU902610D0 (en) 1990-09-28
DD298412A5 (de) 1992-02-20
CA2194103A1 (fr) 1990-10-29
DE69024253T2 (de) 1996-05-15
JPH09132596A (ja) 1997-05-20
EP0696578A2 (fr) 1996-02-14
NO300128B1 (no) 1997-04-14
FI902139A0 (fi) 1990-04-27
JPH0314551A (ja) 1991-01-23
IE69848B1 (en) 1996-10-02
HUT55415A (en) 1991-05-28
DK0395357T3 (da) 1996-01-29
NO901881L (no) 1990-10-29

Similar Documents

Publication Publication Date Title
EP0395357B1 (fr) Polyamines utiles comme antagonistes des neurotransmetteurs excitables par aminoacides et/ou comme bloqueurs des canaux de calcium
EP0436332B1 (fr) Polyamines utiles comme antagonistes des neurotransmetteurs des acides aminés excitateurs
US5599559A (en) Calcium channel blocking polypeptide from agelenopsis aperta and therapeutic methods employing it
US5227397A (en) Polyamines and polypeptides useful as antagonists of excitatory amino acid neuro-transmitters and/or as blockers of calcium channels
US5122596A (en) Polypeptides useful as blockers of calcium channels
US5185369A (en) Synthetic heteroaryl polyamines as excitatory amino acid neurotransmitter antagonists
WO1993004036A1 (fr) Polyamines d'aryle synthetiques utilisees comme antagonistes de neurotransmetteurs d'acides amines de l'excitation
EP0057998A1 (fr) Composés alicycliques, leur préparation et utilisation
CZ282990B6 (cs) Čištěná polypeptidová sloučenina, postup její přípravy a farmaceutický prostředek obsahující tuto sloučeninu
NO315372B1 (no) Vesentlig ren polyaminforbindelse, anvendelse derav og farmasöytiske sammensetninger
FI102171B (fi) Menetelmä terapeuttisesti käyttökelpoisen olennaisen puhtaan polyamiin in ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired